Factors associated with cholestasis after surgery for congenital duodenal atresia

Authors

  • Yosuke Minami
  • Kazuaki Takiguchi
  • Hirofumi Shimizu
  • Hideaki Tanaka Department of Pediatric Surgery, Fukushima Medical University Hospital

DOI:

https://doi.org/10.47338/jns.v12.1158

Keywords:

Duodenal atresia, Postoperative, Cholestasis, Trans-anastomotic tube

Abstract

Background: This study assessed the characteristics of neonates with duodenal atresia (DA) who developed transient postoperative cholestasis which resolved spontaneously, without identifiable congenital anomalies or surgical complications, and identified potential risk factors for cholestasis.

Methods: Neonates with DA who underwent surgery at our institution between January 2009 and July 2022 were retrospectively reviewed. Demographic factors, intraoperative findings, placement of a trans-anastomotic tube (TAT), and postoperative outcomes were compared between patients who developed cholestasis (conjugated hyperbilirubinemia >2.0 mg/dL) after surgery (Group A) and those who did not (Group B). This report is a retrospective cohort study and complies with the STROBE statement.

Results: Among 19 neonates with DA, 6 (31.6%) developed cholestasis after surgery, with the highest direct bilirubin value being 4.3 (2.4-6.5) mg/dL (median, [range]) on postoperative day 14.5 (2-23) that persisted for 67 (47-116) days until spontaneous resolution. Neonates in Group A had a significantly younger gestational age (36.6 vs. 38.0 weeks) (median) (p=0.038), a higher rate of Down syndrome (66.7 vs. 15.4%) (p=0.046), a higher rate of TAT placement (66.7 vs. 15.4%) (p=0.046), and longer administration of total parenteral nutrition (15.5 vs. 7.0 days) (p=0.027) than those in Group B.

Conclusion: Transient cholestasis after surgery for DA seemed to be associated with prematurity, Down syndrome, parenteral nutrition, and TAT placement.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Reid IS. Biliary tract abnormalities associated with duodenal atresia. Arch Dis Child. 1973; 48:952-7. https://doi.org/10.1136/adc.48.12.952

Grosfeld JL, Rescorla FJ. Duodenal atresia and stenosis: reassessment of treatment and outcome based on antenatal diagnosis, pathologic variance, and long-term follow-up. World J Surg. 1993; 17:301–9. https://doi.org/10.1007/BF01658696

Mali V, Wagener S, Sharif K, Millar AJ. Foregut atresias and bile duct anomalies: rare, infrequent, or common? Pediatr Surg Int. 2007; 889–95. Available from: https://doi.org/10.1007/s00383-007-1921-y

Aspirot A, Su W, Flageole H, Puligandla PS, Shaw K, Laberge JM. Cholestasis associated with small bowel atresia: do we always need to investigate? J Pediatr Surg. 2007; 42:873–7. https://doi.org/10.1016/j.jpedsurg.2006.12.053

Toyama C, Masahata K, Ibuka S, Nara K, Soh H, Usui N. The risk factors for cholestasis in patients with duodenal atresia in a single institutional cohort. Pediatr Surg Int. 2021; 37:929–35. Available from: https://doi.org/10.1007/s00383-021-04890-6.

Deguchi K, Tazuke Y, Matsuura R, Nomura M, Yama-naka H, Soh H, et al. Factors associated with adverse outcomes following duodenal atresia surgery in neonates: A retrospective study. Cureus. 2022; 14; e22349. https://doi.org/10.7759/cureus.22349

Champion V, Carbajal R, Lozar J, Girard I, Mitanchez D. Risk factors for developing transient neonatal cholestasis. J Pediatr Gastroenterol Nutr. 2012; 55:592–8. https://doi.org/10.1097/MPG.0b013e3182616916

Ling DXH, Bolisetty S, Krishnan U. Cholestatic jaundice in neonates: How common is biliary atresia? Experience at an Australian tertiary center. J Paediatr Child Health. 2021; 57:87-95. Available from: https://doi.org/10.1111/jpc.15131

Tufano M, Nicastro E, Giliberti P, Veggente A, Raimondi F, Iorio R. Cholestasis in neonatal intensive care unit: incidence, aetiology and management. Acta Paediatr. 2009; 98:1756–61. https://doi.org/10.1111/j.1651-2227.2009.01464.x.

Ravel A, Mircher C, Rebillat AS, Cieuta-Walti C, Meg-arbane A. Feeding problems and gastrointestinal diseases in Down syndrome. Arch Pediatr. 2020; 27:53–60. https://doi.org/10.1016/j.arcped.2019.11.008

Cresner R, Neville JJ, Drewett M, Hall N J, Darwish AA. Use of trans-anastomotic tubes in congenital duodenal obstruction. J Pediatr Surg. 2022; 57:45–8. https://doi.org/10.1016/j.jpedsurg.2022.01.049

Bethell GS, Long AM, Knight M, Hall NJ, BAPS-CASS. Congenital duodenal obstruction in the UK: a population-based study. Arch Dis Child Fetal Neonatal Ed. 2020; 105:178–83. Available from: http://dx.doi.org/10.1136/archdischild-2019-317085

Hile GB, Musick KL, Dugan AJ, Bailey AM, Howington GT. Occurrence of hyperbilirubinemia in neonates given a short-term course of ceftriaxone versus cefotaxime for sepsis. J Pediatr Pharmacol Ther. 2021; 26:99-103. https://doi.org/10.5863/1551-6776-26.1.99

Published

2023-03-23

How to Cite

1.
Minami Y, Takiguchi K, Shimizu H, Tanaka H. Factors associated with cholestasis after surgery for congenital duodenal atresia. J Neonatal Surg [Internet]. 2023Mar.23 [cited 2024Jul.22];12:11. Available from: https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/1158

Issue

Section

Original Article